Known as GLP-1 receptor agonists, the drugs have soared in popularity in recent years, but patient access has been a consistent problem because of their cost around $500 a month for higher doses and insurance coverage has been spotty
Mojca Jensterle has received lecture honoraria from Novo Nordisk, Eli Lilly, Pfizer, Amgen, Novartis and Sanofi, and is an advisory board member of Novo Nordisk, Eli Lilly, Amgen and Pfizer
J Endocrinol Invest 47(2):299306
However, it should be mentioned that taurine levels contribute to cellular homeostasis, and that this role is particularly important in the brain 71 and kidney
It is not yet clear whether these data driven methods for exploring beneficial and harmful drug effects are a genuine advance over traditional inferential approaches
Depending on how your body reacts to the medication, your maintenance dose could be 5, 7.5, 10, 12.5, or 15 mg